Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB (change energy unit to kcal/mol)
Found 125 hits in this display
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
Ki: 9.20nMAssay Description:Displacement of [3H]-citalopram from human SERT expressed in HEK cell membrane assessed as inhibition constant by radioligand binding assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 1.00E+3nMAssay Description:Inhibition of recombinant human NaV1.7 alpha subunit expressed in HEK293 cells at -65 mV holding potential by patch clamp electrophysiological assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 1.60E+3nMAssay Description:Inhibition of human NaV1.5 alpha subunit expressed in CHOK1 cells at -90 mV holding potential by patch clamp electrophysiological assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 3.10E+3nMAssay Description:Inhibition of human NaV1.2 alpha subunit expressed in CHOK1 cells at -65 mV holding potential by patch clamp electrophysiological assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 7.00E+3nMAssay Description:Inhibition of recombinant human NaV1.7 alpha subunit expressed in HEK293 cells at -90 mV holding potential by patch clamp electrophysiological assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 9.60E+3nMAssay Description:Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting methodMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 9.60E+3nMAssay Description:Inhibition of [3H]-dofetilide binding to human ERG expressed in HEK293 cell membranes measured after 1 hr by liquid scintillation counting methodMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 1.69E+4nMAssay Description:Inhibition of 4-(4-(dimethylamino)styryl)-N-methylpyridinium uptake at human OCT1 expressed in HEK293 cells by confocal microscopyMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
IC50: 6.00E+4nMAssay Description:Displacement of [125I]NGF from full length human TrkA expressed in HEKN3S cells cells by gamma counting based radioligand competition assayMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
Kd: 2.10E+6nMAssay Description:Binding affinity to V305 residue of human recombinant TrkAIg2-NMR construct expressed in Escherichia coli by 1H-15N HSQC NMR spectroscopyMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
Kd: 2.20E+6nMAssay Description:Binding affinity to F303 residue of human recombinant TrkAIg2-NMR construct expressed in Escherichia coli by 1H-15N HSQC NMR spectroscopyMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
Kd: 2.10E+6nMAssay Description:Binding affinity to C345 residue of human recombinant TrkAIg2-NMR construct expressed in Escherichia coli by 1H-15N HSQC NMR spectroscopyMore data for this Ligand-Target Pair
BDBM50020712(10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5...)
Kd: 1.80E+6nMAssay Description:Binding affinity to T292 residue of human recombinant TrkAIg2-NMR construct expressed in Escherichia coli by 1H-15N HSQC NMR spectroscopyMore data for this Ligand-Target Pair
Displayed 1 to 50 (of 125 total ) | Next | Last >>